Bill > HR4814

This bill, the Suspicious Order Identification Act of 2019, aims to improve the reporting of the distribution of controlled substances. The key provisions include: 1) Amending the Controlled Substances Act to require all registrants (manufacturers, distributors, etc.) to report every sale, delivery, or disposal of controlled substances in real-time to the Attorney General, rather than the current 30-day timeline. 2) Establishing a Suspicious Order Monitoring Task Force to design and implement a program that will allow for the real-time sharing of data from the Automation of Reports and Consolidated Orders System (ARCOS) with registrants, in order to help them identify and stop suspicious orders. 3) Providing the Attorney General with the authority to use fees collected from registrants under the Controlled Substances Act to fund the implementation and operation of the real-time data sharing program. 4) Requiring all registered drug manufacturers and distributors to review the information provided through the program and comply with any related regulations. The overall goal is to enable more efficient and timely identification and reporting of suspicious orders of controlled substances in order to help reduce the diversion and abuse of these substances.

Business and Industry, Health and Social Services, Military Affairs and Security

https://www.congress.gov/bill/116th-congress/house-bill/4814/all-info